Combination of TATE and PD-1 Inhibitor in Liver Cancer
for Hepatocellular Carcinoma
3 locations incl. Orange
Sponsor: Teclison Ltd.
Sex: All·Age: 18 - 80
Code: NCT03259867·Phase 2·Recruiting
Oklahoma has 836 paid clinical trials enrolling now across cities including Oklahoma City, Tulsa and Edmond. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .